This compound is a brominated benzodiazepine derivative used as a reference standard for impurity testing in pharmaceutical manufacturing. It is a chemical compound with a heterocyclic structure containing amide and aromatic ring systems.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 868350-97-4
11-?Chloro-?N-?methyl-?2-?phenyl-?3-?oxa-?4,?7-?diazatricyclo[6.4.0.?0{2,?4}?]?dodeca-?1(12)?,?6,?8,?10-?tetraen-?6-?amine
benzodiazepine impurity reference standard
REDUCED MIDAZOLAM
benzodiazepine impurity reference standard
Ethyl 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
benzodiazepine impurity reference standard
Carfilzomib
active pharmaceutical ingredient
S-(5'-Adenosyl)-L-methionine chloride dihydrochloride
active pharmaceutical ingredient
Halofuginone
active pharmaceutical ingredient
Umeclidinium bromide
muscarinic antagonist active pharmaceutical ingredient
Methyl (S)-3-(7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanoate
research reagent
7-bromo-5-(6-methyl-2-pyridinyl)-1,3-dihydro-1,4-benzodiazepin-2-one
QZOXQUQNSNCNFD-UHFFFAOYSA-N
CC1=NC(=CC=C1)C2=NCC(=O)NC3=C2C=C(C=C3)Br